SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-039237
Filing Date
2020-03-27
Accepted
2020-03-27 07:23:09
Documents
3
Period of Report
2020-03-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2012940-2_8k.htm 8-K 27450
2 EXHIBIT 99.1 tm2012940d2_ex99-1.htm EX-99.1 130210
3 GRAPHIC tm2012940d2_ex99-1img01.jpg GRAPHIC 3229
  Complete submission text file 0001104659-20-039237.txt   163503
Mailing Address 600 LEE ROAD SUITE 100 WAYNE PA 19087
Business Address 600 LEE ROAD SUITE 100 WAYNE PA 19087 610-833-4200
Zyla Life Sciences (Filer) CIK: 0001586105 (see all company filings)

IRS No.: 463575334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36295 | Film No.: 20748014
SIC: 2834 Pharmaceutical Preparations